Lysosomal degradation of receptor-bound urokinase-type plasminogen activator is enhanced by its inhibitors in human trophoblastic choriocarcinoma cells.
We have studied the effect of plasminogen activator inhibitors PAI-1 and PAI-2 on the binding of urokinase-type plasminogen activator (u-PA) to its receptor in the human choriocarcinoma cell line JAR. With 125I-labeled ligands in whole-cell binding assays, both uncomplexed u-PA and u-PA-inhibitor co...
Guardado en:
| Publicado en: | Cell Regul |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
American Society for Cell Biology
1990
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC361701/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1966892/ https://ncbi.nlm.nih.govhttps://doi.org/10.1091/mbc.1.13.1043 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|